Naglaa M. Hassan

Cairo, C, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Contribution of TP53 and MDM4 Genetic Polymorphisms as a Risk Factor in Non-Hodgkin Lymphoma in Adult Egyptian Patients.

Contribution of TP53 and MDM4 Genetic Polymorphisms as a Risk Factor in Non-Hodgkin Lymphoma in Adult Egyptian Patients.

Journal: Clinical Medicine Insights. Oncology

Published: December 25, 2024

PTCSC3, XIST, GAS5, UCA1, and HIFAL: Five lncRNAs Emerging as Potential Prognostic Players in Egyptian Adult Acute Myeloid Leukemia (AML) Patients.

PTCSC3, XIST, GAS5, UCA1, and HIFAL: Five lncRNAs Emerging as Potential Prognostic Players in Egyptian Adult Acute Myeloid Leukemia (AML) Patients.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: December 14, 2024

A significant correlation exists between CREBBP and CEBPA gene expression in de Novo adult acute myeloid leukemia.

A significant correlation exists between CREBBP and CEBPA gene expression in de Novo adult acute myeloid leukemia.

Journal: Scientific reports

Published: November 09, 2024

Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.

Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.

Journal: Oncology research

Published: June 20, 2023

SMYD2 Expression: Its Relationship to Cytogenetic and Prognosis in a Newly Diagnosed Childhood B-Acute Lymphoblastic Leukemia.

SMYD2 Expression: Its Relationship to Cytogenetic and Prognosis in a Newly Diagnosed Childhood B-Acute Lymphoblastic Leukemia.

Journal: Clinical laboratory

Published: March 13, 2023

Clinical significance of EVI-1 gene expression and aberrations in patient with de-novo acute myeloid and acute lymphoid leukemia.

Clinical significance of EVI-1 gene expression and aberrations in patient with de-novo acute myeloid and acute lymphoid leukemia.

Journal: Leukemia research

Published: November 17, 2022

Clinical and Molecular Characteristics of Patients with Mixed Phenotype Acute Leukemia.

Clinical and Molecular Characteristics of Patients with Mixed Phenotype Acute Leukemia.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: November 08, 2022

Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia.

Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia.

Journal: Journal of the Egyptian National Cancer Institute

Published: August 15, 2022

The prognostic role of C-KIT, TET1 and TET2 gene expression in Acute Myeloid Leukemia.

The prognostic role of C-KIT, TET1 and TET2 gene expression in Acute Myeloid Leukemia.

Journal: Molecular biology reports

Published: August 02, 2022

Cancer Stem Cells as a Prognostic Biomarker and Therapeutic Target Using Curcumin/ Piperine Extract for Multiple Myeloma.

Cancer Stem Cells as a Prognostic Biomarker and Therapeutic Target Using Curcumin/ Piperine Extract for Multiple Myeloma.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: June 07, 2022

Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients.

Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients.

Journal: Pharmacogenomics and personalized medicine

Published: March 30, 2022

Expression and prognostic significance of chromatin modulators EHMT2/G9a and KDM2b in acute myeloid leukemia.

Expression and prognostic significance of chromatin modulators EHMT2/G9a and KDM2b in acute myeloid leukemia.

Journal: Journal of cellular biochemistry

Published: February 03, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026